Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: FMX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on FMX, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 950,878 FMX shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 950,878 shares
    Change vs previous 13F -45,682 shares

    2.23% of the 13F portfolio, value $121,617,296.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 996,560 shares
    Change vs previous 13F +33,870 shares

    2.13% of the 13F portfolio, value $110,677,954.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 962,690 shares
    Change vs previous 13F -182,190 shares

    2.04% of the 13F portfolio, value $97,306,374.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,144,880 shares
    Change vs previous 13F +222,064 shares

    2.53% of the 13F portfolio, value $112,928,033.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 922,816 shares
    Change vs previous 13F +3,094 shares

    2.95% of the 13F portfolio, value $95,038,842.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 919,722 shares
    Change vs previous 13F +103,983 shares

    2.81% of the 13F portfolio, value $89,753,674.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 815,739 shares
    Change vs previous 13F +180,244 shares

    2.42% of the 13F portfolio, value $69,743,159.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 635,495 shares
    Change vs previous 13F not available

    2.17% of the 13F portfolio, value $62,734,233.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).